ammonium tungsten antimonate hydroxide oxide and HIV Coinfection

ammonium tungsten antimonate hydroxide oxide has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burgard, M; Descamps, P; Guetard, D; Herson, S; Rouzioux, C; Rozenbaum, W; Sansonetti, P; Vittecoq, D	1

Trials

1 trial(s) available for ammonium tungsten antimonate hydroxide oxide and HIV Coinfection

Article	Year
Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS. AIDS (London, England), 1989, Volume: 3, Issue:10 Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins	1989

Article

Year

Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

AIDS (London, England), 1989, Volume: 3, Issue:10

Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins

1989